116 related articles for article (PubMed ID: 1492226)
1. Etoposide in the treatment of leukemias.
Bishop JF
Semin Oncol; 1992 Dec; 19(6 Suppl 13):33-8. PubMed ID: 1492226
[TBL] [Abstract][Full Text] [Related]
2. Etoposide in leukemia.
Bishop JF; Lowethal R; Joshua D; Matthews JP; Wolf MM; Cooper IA
Cancer; 1991 Jan; 67(1 Suppl):285-91. PubMed ID: 1984829
[TBL] [Abstract][Full Text] [Related]
3. Etoposide in the management of leukemia: a review.
Bishop JF
Semin Oncol; 1991 Feb; 18(1 Suppl 2):62-9. PubMed ID: 1992536
[TBL] [Abstract][Full Text] [Related]
4. Phase II trial of amsacrine plus intermediate-dose Ara-C (IDAC) with or without etoposide as salvage therapy for refractory or relapsed acute leukemia.
Sung WJ; Kim DH; Sohn SK; Kim JG; Baek JH; Jeon SB; Moon JH; Ahn BM; Lee KB
Jpn J Clin Oncol; 2005 Oct; 35(10):612-6. PubMed ID: 16172175
[TBL] [Abstract][Full Text] [Related]
5. Amsacrine alone or in combination with 5-azacytidine and etoposide in refractory or relapsed acute non lymphoblastic leukemia (ANLL).
Carella AM; Santini G; Martinengo M; Nati S; Giordano D; Congiu A; Cerri R; Damasio E; Risso M; Rossi E
Haematologica; 1985; 70(1):39-43. PubMed ID: 2408974
[No Abstract] [Full Text] [Related]
6. Etoposide and teniposide in the treatment of acute leukemia.
Björkholm M
Med Oncol Tumor Pharmacother; 1990; 7(1):3-10. PubMed ID: 2187120
[TBL] [Abstract][Full Text] [Related]
7. Etoposide in acute leukemia. Past experience and future perspectives.
Ho AD; Brado B; Haas R; Hunstein W
Cancer; 1991 Jan; 67(1 Suppl):281-4. PubMed ID: 1984828
[TBL] [Abstract][Full Text] [Related]
8. Mitoxantrone in combination with etoposide and cytarabine for treatment of poor prognosis acute non lymphoid leukemia patients.
Tribalto M; Cantonetti M; Catalano G; Del Poeta G; Masi M; Pastore S; Pisani F; Stasi R; Papa G
Haematologica; 1991; 76(5):402-5. PubMed ID: 1806445
[TBL] [Abstract][Full Text] [Related]
9. [Treatment results of acute nonlymphocytic leukemia in childhood--Kyushu Yamaguchi Children's Cancer Study Group].
Ikuno Y; Okamura J; Ishii E; Matuzaki A; Ueda K; Eguchi H; Inada H; Nibu K; Koga H; Miyazaki S
Rinsho Ketsueki; 1995 Apr; 36(4):325-33. PubMed ID: 7783338
[TBL] [Abstract][Full Text] [Related]
10. Treatment of relapsed aggressive lymphomas: regimens with and without high-dose therapy and stem cell rescue.
Hagemeister FB
Cancer Chemother Pharmacol; 2002 May; 49 Suppl 1():S13-20. PubMed ID: 12042984
[TBL] [Abstract][Full Text] [Related]
11. Induction failures in childhood acute nonlymphocytic leukemia: etoposide/5-azacytidine for cases refractory to daunorubicin/cytarabine.
Kalwinsky DK; Dahl GV; Mirro J; Jackson CW; Look AT
Med Pediatr Oncol; 1986; 14(5):245-50. PubMed ID: 2431255
[TBL] [Abstract][Full Text] [Related]
12. Acute myeloid leukemia complicating multiple myeloma: a case successfully treated with etoposide, thioguanine, and cytarabine.
Erikci AA; Ozturk A; Tekgunduz E; Sayan O
Clin Lymphoma Myeloma; 2009 Aug; 9(4):E14-5. PubMed ID: 19717372
[TBL] [Abstract][Full Text] [Related]
13. Mitoxantrone, etoposide and cytarabine in the treatment of acute nonlymphocytic leukemia.
Björkholm M; Björnsdottir J; Stenke L; Grimfors G
Oncology; 1990; 47(2):112-4. PubMed ID: 2314823
[TBL] [Abstract][Full Text] [Related]
14. Idarubicin in combination with etoposide and cytarabine in adult acute non-lymphoblastic leukaemia (ANLL).
Carella AM; Pungolino E; Piatti G; Giordano D; Cerri R; Risso M; Nati S
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():50-1. PubMed ID: 2713562
[No Abstract] [Full Text] [Related]
15. The combination of fludarabine, cytarabine and etoposide is an active and well-tolerated regimen in relapsed/refractory acute myeloid leukemia.
Aldoss I; Ji L; Haider M; Pullarkat V
Acta Haematol; 2014; 131(4):202-7. PubMed ID: 24296475
[TBL] [Abstract][Full Text] [Related]
16. Etoposide in remission induction of adult acute myeloid leukemia.
Leoni F; Ciolli S; Patriarchi S; Morfini M; Rossi Ferrini P
Acta Haematol; 1990; 83(2):82-5. PubMed ID: 2106200
[TBL] [Abstract][Full Text] [Related]
17. Effective salvage therapy for high-risk relapsed or refractory acute myeloid leukaemia with cisplatin in combination with high-dose cytarabine and etoposide.
Lee YG; Kwon JH; Kim I; Yoon SS; Lee JS; Park S
Eur J Haematol; 2014 Jun; 92(6):478-84. PubMed ID: 24460733
[TBL] [Abstract][Full Text] [Related]
18. Efficacy and clinical cross-resistance of a new combination therapy (AMSA/VP16) in previously treated patients with acute nonlymphocytic leukemia.
Tschopp L; von Fliedner VE; Sauter C; Maurice P; Gratwohl A; Fopp M; Cavalli F
J Clin Oncol; 1986 Mar; 4(3):318-24. PubMed ID: 3456425
[TBL] [Abstract][Full Text] [Related]
19. [Chemotherapy of adult ANLL].
Kyo T; Maehama S
Rinsho Ketsueki; 1989 Aug; 30(8):1157-62. PubMed ID: 2601024
[TBL] [Abstract][Full Text] [Related]
20. Amsacrine, cytarabine and thioguanine (AAT) versus daunorubicin, cytarabine, thioguanine (DAT) in adults with untreated acute non-lymphoblastic leukemia (ANLL). Austrian-German results.
Linkesch W; Michlmayr G; Gerhartz H; Illinger H; König H; Düllmann J; Keilhauer R; Moldrzyk D
Onkologie; 1989 Feb; 12(1):8-10. PubMed ID: 2654791
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
